Tenet Healthcare Corporation (THC) Q4 FY25 Earnings Call

USPI growth and capital deployment support 2026, while exchange-credit expiration creates a quantified $250 million EBITDA headwind. [6] [25]

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-11
Length53 minutes
EPS$4.70
EPS consensus$4.08
Revenue$5.3B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q1 FY26 · Q2 FY25

All THC earnings · Back to THC overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.